Global Serplulimab Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

September 2026 | 82 pages | ID: G2DA6D82CE75EN
GlobalInfoResearch

Abstracts

According to our (Global Info Research) latest study, the global Serplulimab Injection market size was valued at US$ 6.16 million in 2025 and is forecast to a readjusted size of US$ 79.88 million by 2032 with a CAGR of 44.7% during review period.

Serplulimab (also known as HLX 10) is a recombinant, humanised, anti-PD1 monoclonal antibody, being developed by Shanghai Henlius Biotech.

This report is a detailed and comprehensive analysis for global Serplulimab Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Serplulimab Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032

Global Serplulimab Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032

Global Serplulimab Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032

Global Serplulimab Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026

The Primary Objectives in This Report Are:

• To determine the size of the total market opportunity of global and key countries
• To assess the growth potential for Serplulimab Injection
• To forecast future growth in each product and end-use market
• To assess competitive factors affecting the marketplace

This report profiles key players in the global Serplulimab Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Henlius Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Serplulimab Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

• 100mg/10ml
• Others

Market segment by Application

• Hospitals
• Clinics
• Others

Major players covered

• Shanghai Henlius Biotech

Market segment by region, regional analysis covers

• North America (United States, Canada, and Mexico)
• Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
• South America (Brazil, Argentina, Colombia, and Rest of South America)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Serplulimab Injection product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Serplulimab Injection, with price, sales quantity, revenue, and global market share of Serplulimab Injection from 2021 to 2026.

Chapter 3, the Serplulimab Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Serplulimab Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Serplulimab Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Serplulimab Injection.

Chapter 14 and 15, to describe Serplulimab Injection sales channel, distributors, customers, research findings and conclusion.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Serplulimab Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
  1.3.2 100mg/10ml
  1.3.3 Others
1.4 Market Analysis by Application
  1.4.1 Overview: Global Serplulimab Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
  1.4.2 Hospitals
  1.4.3 Clinics
  1.4.4 Others
1.5 Global Serplulimab Injection Market Size & Forecast
  1.5.1 Global Serplulimab Injection Consumption Value (2021 & 2025 & 2032)
  1.5.2 Global Serplulimab Injection Sales Quantity (2021-2032)
  1.5.3 Global Serplulimab Injection Average Price (2021-2032)

2 MANUFACTURERS PROFILES

2.1 Shanghai Henlius Biotech
  2.1.1 Shanghai Henlius Biotech Details
  2.1.2 Shanghai Henlius Biotech Major Business
  2.1.3 Shanghai Henlius Biotech Serplulimab Injection Product and Services
  2.1.4 Shanghai Henlius Biotech Serplulimab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Shanghai Henlius Biotech Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: SERPLULIMAB INJECTION BY MANUFACTURER

3.1 Global Serplulimab Injection Sales Quantity by Manufacturer (2021-2026)
3.2 Global Serplulimab Injection Revenue by Manufacturer (2021-2026)
3.3 Global Serplulimab Injection Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
  3.4.1 Producer Shipments of Serplulimab Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
  3.4.2 Top 3 Serplulimab Injection Manufacturer Market Share in 2025
  3.4.3 Top 6 Serplulimab Injection Manufacturer Market Share in 2025
3.5 Serplulimab Injection Market: Overall Company Footprint Analysis
  3.5.1 Serplulimab Injection Market: Region Footprint
  3.5.2 Serplulimab Injection Market: Company Product Type Footprint
  3.5.3 Serplulimab Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Serplulimab Injection Market Size by Region
  4.1.1 Global Serplulimab Injection Sales Quantity by Region (2021-2032)
  4.1.2 Global Serplulimab Injection Consumption Value by Region (2021-2032)
  4.1.3 Global Serplulimab Injection Average Price by Region (2021-2032)
4.2 North America Serplulimab Injection Consumption Value (2021-2032)
4.3 Europe Serplulimab Injection Consumption Value (2021-2032)
4.4 Asia-Pacific Serplulimab Injection Consumption Value (2021-2032)
4.5 South America Serplulimab Injection Consumption Value (2021-2032)
4.6 Middle East & Africa Serplulimab Injection Consumption Value (2021-2032)

5 MARKET SEGMENT BY TYPE

5.1 Global Serplulimab Injection Sales Quantity by Type (2021-2032)
5.2 Global Serplulimab Injection Consumption Value by Type (2021-2032)
5.3 Global Serplulimab Injection Average Price by Type (2021-2032)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Serplulimab Injection Sales Quantity by Application (2021-2032)
6.2 Global Serplulimab Injection Consumption Value by Application (2021-2032)
6.3 Global Serplulimab Injection Average Price by Application (2021-2032)

7 NORTH AMERICA

7.1 North America Serplulimab Injection Sales Quantity by Type (2021-2032)
7.2 North America Serplulimab Injection Sales Quantity by Application (2021-2032)
7.3 North America Serplulimab Injection Market Size by Country
  7.3.1 North America Serplulimab Injection Sales Quantity by Country (2021-2032)
  7.3.2 North America Serplulimab Injection Consumption Value by Country (2021-2032)
  7.3.3 United States Market Size and Forecast (2021-2032)
  7.3.4 Canada Market Size and Forecast (2021-2032)
  7.3.5 Mexico Market Size and Forecast (2021-2032)

8 EUROPE

8.1 Europe Serplulimab Injection Sales Quantity by Type (2021-2032)
8.2 Europe Serplulimab Injection Sales Quantity by Application (2021-2032)
8.3 Europe Serplulimab Injection Market Size by Country
  8.3.1 Europe Serplulimab Injection Sales Quantity by Country (2021-2032)
  8.3.2 Europe Serplulimab Injection Consumption Value by Country (2021-2032)
  8.3.3 Germany Market Size and Forecast (2021-2032)
  8.3.4 France Market Size and Forecast (2021-2032)
  8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  8.3.6 Russia Market Size and Forecast (2021-2032)
  8.3.7 Italy Market Size and Forecast (2021-2032)

9 ASIA-PACIFIC

9.1 Asia-Pacific Serplulimab Injection Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Serplulimab Injection Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Serplulimab Injection Market Size by Region
  9.3.1 Asia-Pacific Serplulimab Injection Sales Quantity by Region (2021-2032)
  9.3.2 Asia-Pacific Serplulimab Injection Consumption Value by Region (2021-2032)
  9.3.3 China Market Size and Forecast (2021-2032)
  9.3.4 Japan Market Size and Forecast (2021-2032)
  9.3.5 South Korea Market Size and Forecast (2021-2032)
  9.3.6 India Market Size and Forecast (2021-2032)
  9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  9.3.8 Australia Market Size and Forecast (2021-2032)

10 SOUTH AMERICA

10.1 South America Serplulimab Injection Sales Quantity by Type (2021-2032)
10.2 South America Serplulimab Injection Sales Quantity by Application (2021-2032)
10.3 South America Serplulimab Injection Market Size by Country
  10.3.1 South America Serplulimab Injection Sales Quantity by Country (2021-2032)
  10.3.2 South America Serplulimab Injection Consumption Value by Country (2021-2032)
  10.3.3 Brazil Market Size and Forecast (2021-2032)
  10.3.4 Argentina Market Size and Forecast (2021-2032)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Serplulimab Injection Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Serplulimab Injection Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Serplulimab Injection Market Size by Country
  11.3.1 Middle East & Africa Serplulimab Injection Sales Quantity by Country (2021-2032)
  11.3.2 Middle East & Africa Serplulimab Injection Consumption Value by Country (2021-2032)
  11.3.3 Turkey Market Size and Forecast (2021-2032)
  11.3.4 Egypt Market Size and Forecast (2021-2032)
  11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  11.3.6 South Africa Market Size and Forecast (2021-2032)

12 MARKET DYNAMICS

12.1 Serplulimab Injection Market Drivers
12.2 Serplulimab Injection Market Restraints
12.3 Serplulimab Injection Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Serplulimab Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Serplulimab Injection
13.3 Serplulimab Injection Production Process
13.4 Industry Value Chain Analysis

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Serplulimab Injection Typical Distributors
14.3 Serplulimab Injection Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Serplulimab Injection Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Serplulimab Injection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Shanghai Henlius Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Shanghai Henlius Biotech Major Business
Table 5. Shanghai Henlius Biotech Serplulimab Injection Product and Services
Table 6. Shanghai Henlius Biotech Serplulimab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Shanghai Henlius Biotech Recent Developments/Updates
Table 8. Global Serplulimab Injection Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 9. Global Serplulimab Injection Revenue by Manufacturer (2021-2026) & (USD Million)
Table 10. Global Serplulimab Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 11. Market Position of Manufacturers in Serplulimab Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 12. Head Office and Serplulimab Injection Production Site of Key Manufacturer
Table 13. Serplulimab Injection Market: Company Product Type Footprint
Table 14. Serplulimab Injection Market: Company Product Application Footprint
Table 15. Serplulimab Injection New Market Entrants and Barriers to Market Entry
Table 16. Serplulimab Injection Mergers, Acquisition, Agreements, and Collaborations
Table 17. Global Serplulimab Injection Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 18. Global Serplulimab Injection Sales Quantity by Region (2021-2026) & (K Units)
Table 19. Global Serplulimab Injection Sales Quantity by Region (2027-2032) & (K Units)
Table 20. Global Serplulimab Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 21. Global Serplulimab Injection Consumption Value by Region (2027-2032) & (USD Million)
Table 22. Global Serplulimab Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 23. Global Serplulimab Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 24. Global Serplulimab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 25. Global Serplulimab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 26. Global Serplulimab Injection Consumption Value by Type (2021-2026) & (USD Million)
Table 27. Global Serplulimab Injection Consumption Value by Type (2027-2032) & (USD Million)
Table 28. Global Serplulimab Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 29. Global Serplulimab Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 30. Global Serplulimab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 31. Global Serplulimab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 32. Global Serplulimab Injection Consumption Value by Application (2021-2026) & (USD Million)
Table 33. Global Serplulimab Injection Consumption Value by Application (2027-2032) & (USD Million)
Table 34. Global Serplulimab Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 35. Global Serplulimab Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 36. North America Serplulimab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 37. North America Serplulimab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 38. North America Serplulimab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 39. North America Serplulimab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 40. North America Serplulimab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 41. North America Serplulimab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 42. North America Serplulimab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 43. North America Serplulimab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 44. Europe Serplulimab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 45. Europe Serplulimab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 46. Europe Serplulimab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 47. Europe Serplulimab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 48. Europe Serplulimab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 49. Europe Serplulimab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 50. Europe Serplulimab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 51. Europe Serplulimab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 52. Asia-Pacific Serplulimab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 53. Asia-Pacific Serplulimab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 54. Asia-Pacific Serplulimab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 55. Asia-Pacific Serplulimab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 56. Asia-Pacific Serplulimab Injection Sales Quantity by Region (2021-2026) & (K Units)
Table 57. Asia-Pacific Serplulimab Injection Sales Quantity by Region (2027-2032) & (K Units)
Table 58. Asia-Pacific Serplulimab Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 59. Asia-Pacific Serplulimab Injection Consumption Value by Region (2027-2032) & (USD Million)
Table 60. South America Serplulimab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 61. South America Serplulimab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 62. South America Serplulimab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 63. South America Serplulimab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 64. South America Serplulimab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 65. South America Serplulimab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 66. South America Serplulimab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 67. South America Serplulimab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 68. Middle East & Africa Serplulimab Injection Sales Quantity by Type (2021-2026) & (K Units)
Table 69. Middle East & Africa Serplulimab Injection Sales Quantity by Type (2027-2032) & (K Units)
Table 70. Middle East & Africa Serplulimab Injection Sales Quantity by Application (2021-2026) & (K Units)
Table 71. Middle East & Africa Serplulimab Injection Sales Quantity by Application (2027-2032) & (K Units)
Table 72. Middle East & Africa Serplulimab Injection Sales Quantity by Country (2021-2026) & (K Units)
Table 73. Middle East & Africa Serplulimab Injection Sales Quantity by Country (2027-2032) & (K Units)
Table 74. Middle East & Africa Serplulimab Injection Consumption Value by Country (2021-2026) & (USD Million)
Table 75. Middle East & Africa Serplulimab Injection Consumption Value by Country (2027-2032) & (USD Million)
Table 76. Serplulimab Injection Raw Material
Table 77. Key Manufacturers of Serplulimab Injection Raw Materials
Table 78. Serplulimab Injection Typical Distributors
Table 79. Serplulimab Injection Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Serplulimab Injection Picture
Figure 2. Global Serplulimab Injection Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Serplulimab Injection Revenue Market Share by Type in 2025
Figure 4. 100mg/10ml Examples
Figure 5. Others Examples
Figure 6. Global Serplulimab Injection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Serplulimab Injection Revenue Market Share by Application in 2025
Figure 8. Hospitals Examples
Figure 9. Clinics Examples
Figure 10. Others Examples
Figure 11. Global Serplulimab Injection Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Serplulimab Injection Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Serplulimab Injection Sales Quantity (2021-2032) & (K Units)
Figure 14. Global Serplulimab Injection Price (2021-2032) & (US$/Unit)
Figure 15. Global Serplulimab Injection Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global Serplulimab Injection Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of Serplulimab Injection by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 Serplulimab Injection Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 Serplulimab Injection Manufacturer (Revenue) Market Share in 2025
Figure 20. Global Serplulimab Injection Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global Serplulimab Injection Consumption Value Market Share by Region (2021-2032)
Figure 22. North America Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 25. South America Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 27. Global Serplulimab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global Serplulimab Injection Consumption Value Market Share by Type (2021-2032)
Figure 29. Global Serplulimab Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 30. Global Serplulimab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global Serplulimab Injection Revenue Market Share by Application (2021-2032)
Figure 32. Global Serplulimab Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 33. North America Serplulimab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America Serplulimab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America Serplulimab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America Serplulimab Injection Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Serplulimab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe Serplulimab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe Serplulimab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe Serplulimab Injection Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 45. France Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Serplulimab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific Serplulimab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific Serplulimab Injection Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific Serplulimab Injection Consumption Value Market Share by Region (2021-2032)
Figure 53. China Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 56. India Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 59. South America Serplulimab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America Serplulimab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America Serplulimab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America Serplulimab Injection Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa Serplulimab Injection Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa Serplulimab Injection Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa Serplulimab Injection Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa Serplulimab Injection Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa Serplulimab Injection Consumption Value (2021-2032) & (USD Million)
Figure 73. Serplulimab Injection Market Drivers
Figure 74. Serplulimab Injection Market Restraints
Figure 75. Serplulimab Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Serplulimab Injection in 2025
Figure 78. Manufacturing Process Analysis of Serplulimab Injection
Figure 79. Serplulimab Injection Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source